Pelizza Lorenzo, Federico Antonio, Leuci Emanuela, Quattrone Emanuela, Palmisano Derna, Pupo Simona, Paulillo Giuseppina, Pellegrini Clara, Pellegrini Pietro, Menchetti Marco
Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum - Università di Bologna, Bologna, (BO), Italy; Department of Mental Health and Pathological Addiction, Azienda USL di Parma, Parma, (PR), Italy.
Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum - Università di Bologna, Bologna, (BO), Italy.
J Psychiatr Res. 2025 Jun;186:407-415. doi: 10.1016/j.jpsychires.2025.04.041. Epub 2025 Apr 22.
The PANSS Autism Severity Score (PAUSS) is a recent popular measure of autistic characteristics in Schizophrenia Spectrum Disorders (SSD). Evidence on its factor structure, longitudinal course, and treatment response is poor. The main aims of this investigation were: to examine its internal consistency and factor configuration in young patients with first-episode SSD treated in an Early Intervention (EI) service, and to compare clinical outcomes between SSD individuals with or without "autistic features" across 2 years of follow-up, as well as their treatment response.
SSD participants completed the Positive And Negative Syndrome Scale (PANSS), the Global Assessment of Functioning (GAF), and the Health of the Nation Outcome Scale (HoNOS) across the follow-up. Statistical tests included the α statistic, Exploratory Factor Analysis, Kaplan-Meyer survival analysis, mixed-design ANOVA, and multiple linear regression analysis.
170 SSD individuals were enrolled (58 [34.1 %] scoring above the PAUSS cut-off [PAUSS+]). Internal consistency of the PAUSS was acceptable (α = .792). EFA identified a 3-factor model. At baseline, PAUSS + individuals showed greater severity in psychopathology and social decline. Across the follow-up, PAUSS + individuals had lower incidence rates of symptomatic remission. No PAUSS long-term stability was found, but a significant reduction that was predicted by lower antipsychotic dosage and higher number of case management sessions offered along the follow-up.
The PAUSS seems to capture a SSD subgroup characterized by higher baseline severity levels in psychopathology and poorer outcomes.
PANSS自闭症严重程度评分(PAUSS)是近期用于评估精神分裂症谱系障碍(SSD)中自闭症特征的常用指标。但其因子结构、纵向病程及治疗反应方面的证据尚不充分。本研究的主要目的是:在早期干预(EI)服务中接受治疗的首发SSD年轻患者中,检验其内部一致性和因子构型;比较在2年随访期内有或无“自闭症特征”的SSD个体的临床结局及其治疗反应。
SSD参与者在随访期间完成阳性与阴性症状量表(PANSS)、功能总体评定量表(GAF)及国民健康结果量表(HoNOS)。统计检验包括α统计量、探索性因子分析、Kaplan-Meier生存分析、混合设计方差分析及多元线性回归分析。
共纳入170例SSD个体(58例[34.1%]得分高于PAUSS临界值[PAUSS+])。PAUSS的内部一致性可接受(α = 0.792)。探索性因子分析确定了一个三因子模型。在基线时,PAUSS+个体在精神病理学和社会功能衰退方面表现出更高的严重程度。在整个随访期间,PAUSS+个体症状缓解的发生率较低。未发现PAUSS的长期稳定性,但随访期间抗精神病药物剂量较低及个案管理次数较多可预测其显著降低。
PAUSS似乎捕捉到了一个以精神病理学基线严重程度较高和预后较差为特征的SSD亚组。